Acute Q fever in patients with an influenza-like illness in regional New South Wales, Australia

PLoS Negl Trop Dis. 2024 Aug 5;18(8):e0012385. doi: 10.1371/journal.pntd.0012385. eCollection 2024 Aug.

Abstract

Introduction: Query (Q) fever is a zoonosis caused by the bacterium Coxiella burnetii typically presenting as an influenza-like illness (ILI) with or without hepatitis. The infection may be missed by clinicians in settings of low endemicity, as the presentation is clinically not specific, and there are many more common differential diagnoses for ILI including SARS-CoV-2 infection.

Methods: Residual serum samples were retrospectively tested for Phase 1 and 2 Q fever-specific IgM, IgG, IgA antibodies by indirect immunofluorescence and C. burnetii DNA by polymerase chain reaction. They had not been previously tested for Q fever, originating from undiagnosed patients with probable ILI, aged 10-70 years and living in regional New South Wales, Australia. The results were compared with contemperaneous data on acute Q fever diagnostic tests which had been performed based on clinicians requests from a geographically similar population.

Results: Only one (0.2%) instance of missed acute Q fever was identified after testing samples from 542 eligible patients who had probable ILI between 2016-2023. Laboratory data showed that during the same period, 731 samples were tested for acute Q fever for clinician-initiated requests and of those 70 (9.6%) were positive. Probability of being diagnosed with Q fever after a clinician initiated request was similar regardless of the patients sex, age and the calendar year of sampling.

Conclusion: In this sample, Q fever was most likely to be diagnosed via clinician requested testing rather than by testing of undiagnosed patients with an influenza like illness.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Bacterial / blood
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • Child
  • Coxiella burnetii* / genetics
  • Coxiella burnetii* / immunology
  • Coxiella burnetii* / isolation & purification
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunoglobulin M / blood
  • Influenza, Human* / diagnosis
  • Influenza, Human* / epidemiology
  • Influenza, Human* / virology
  • Male
  • Middle Aged
  • New South Wales / epidemiology
  • Q Fever* / diagnosis
  • Q Fever* / epidemiology
  • Retrospective Studies
  • Young Adult

Substances

  • Antibodies, Bacterial
  • Immunoglobulin M

Grants and funding

This work was funded by CSL Seqirus Australia which produces the Q fever vaccine in Australia. The grant (QFE-21-001-Rodrigo) was received by CR and ARL. CSL Seqirus (Australia) had no role in the study design, study conduct, analysis or data interpretation. Prior to publication, CSL Seqirus had the opportunity to review the manuscript and provide comment on factual inaccuracies, if identified.